Dr. Reddy's Laboratories (RDY) Is Up Sharply After FDA Approval
Markets2018-06-15
0 Views
Dr. Reddy's Laboratories (RDY) announced after the bell Thursday that it has received approval from the FDA for Buprenorphine and Naloxone Sublingual Film, a generic version of Suboxone.
Source: RTTNews
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Tesla (Nasdaq: TSLA) Announces Date for First Quarter 2021 Financial Results and Webcast
